Safety Study of Percutaneous Gastroscopic Gastrostomy in Patients After Ventriculoperitoneal Shunt
Objective To evaluate the safety study of percutaneous gastroscopic gastrostomy in patients after ventriculoperitoneal shunt. Methods We conducted a retrospective analysis of neurosurgical patients who underwent VPS and PEG at our hospital between January 2012 and November 2023. Patients were divide...
Gespeichert in:
Veröffentlicht in: | The American surgeon 2024-12, Vol.90 (12), p.3262-3266 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 3266 |
---|---|
container_issue | 12 |
container_start_page | 3262 |
container_title | The American surgeon |
container_volume | 90 |
creator | Wang, Dexian Peng, Run Huang, Yebin Zhou, Jun Long, Zhihua Wang, Jianjun Zhang, Dejian |
description | Objective
To evaluate the safety study of percutaneous gastroscopic gastrostomy in patients after ventriculoperitoneal shunt.
Methods
We conducted a retrospective analysis of neurosurgical patients who underwent VPS and PEG at our hospital between January 2012 and November 2023. Patients were divided into 2 groups: VPS group and VPS followed by PEG gruop. Patients received routine antibiotic prophylaxis before the procedure, continued for 48 hours. Follow-up included monitoring immediate complications, particularly wound infection, intracranial infection, neurologic status deterioration, and shunt dysfunction. Routine follow-up visits were conducted post-discharge.
Results
In the VPS group (n = 778), the incidence of intracranial infection was 3.08%. Among patients with PEG after VPS, the time interval between procedures ranged from 13 to 685 days. The mean follow-up period was 22 (1-77) months, with no deaths or further complications.
Conclusion
Performing PEG more than 13 days after VPS does not significantly increase the risk of intracranial infections or PEG-associated infections, making it a relatively safe procedure. |
doi_str_mv | 10.1177/00031348241265147 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3082835032</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_00031348241265147</sage_id><sourcerecordid>3121198391</sourcerecordid><originalsourceid>FETCH-LOGICAL-c250t-1d3a366b6d2bcae19b320df107e1f7bc4c59b133f29c6509649e0334b591694b3</originalsourceid><addsrcrecordid>eNp1kUtLxDAQx4Mo7vr4AF4k4MVLNZNp2uYo4gsWFFa9liRNtdJt1iQ97Lc3y_oAxdPMML_5z4uQI2BnAGV5zhhDwLziOfBCQF5ukSkIITJZcdwm03U-WwMTshfCWwrzhO2SCUqGrCj5lOi5am1c0XkcmxV1LX2w3oxRDdaNgd6oEL0Lxi078xVEt1jRbqAPKnZ2iIFetNF6-px835mxd0vru-gGq3o6fx2HeEB2WtUHe_hp98nT9dXj5W02u7-5u7yYZYYLFjNoUGFR6KLh2igLUiNnTQustNCW2uRGSA2ILZemEEwWubQMMddCQiFzjfvkdKO79O59tCHWiy4Y2_ebZWpkFa9QMOQJPfmFvrnRD2m6GoEDyAolJAo2lElrB2_beum7hfKrGli9fkD95wGp5vhTedQL23xXfF08AWcbIKgX-9P2f8UPda2NWQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3121198391</pqid></control><display><type>article</type><title>Safety Study of Percutaneous Gastroscopic Gastrostomy in Patients After Ventriculoperitoneal Shunt</title><source>MEDLINE</source><source>SAGE Complete A-Z List</source><creator>Wang, Dexian ; Peng, Run ; Huang, Yebin ; Zhou, Jun ; Long, Zhihua ; Wang, Jianjun ; Zhang, Dejian</creator><creatorcontrib>Wang, Dexian ; Peng, Run ; Huang, Yebin ; Zhou, Jun ; Long, Zhihua ; Wang, Jianjun ; Zhang, Dejian</creatorcontrib><description>Objective
To evaluate the safety study of percutaneous gastroscopic gastrostomy in patients after ventriculoperitoneal shunt.
Methods
We conducted a retrospective analysis of neurosurgical patients who underwent VPS and PEG at our hospital between January 2012 and November 2023. Patients were divided into 2 groups: VPS group and VPS followed by PEG gruop. Patients received routine antibiotic prophylaxis before the procedure, continued for 48 hours. Follow-up included monitoring immediate complications, particularly wound infection, intracranial infection, neurologic status deterioration, and shunt dysfunction. Routine follow-up visits were conducted post-discharge.
Results
In the VPS group (n = 778), the incidence of intracranial infection was 3.08%. Among patients with PEG after VPS, the time interval between procedures ranged from 13 to 685 days. The mean follow-up period was 22 (1-77) months, with no deaths or further complications.
Conclusion
Performing PEG more than 13 days after VPS does not significantly increase the risk of intracranial infections or PEG-associated infections, making it a relatively safe procedure.</description><identifier>ISSN: 0003-1348</identifier><identifier>ISSN: 1555-9823</identifier><identifier>EISSN: 1555-9823</identifier><identifier>DOI: 10.1177/00031348241265147</identifier><identifier>PMID: 39030672</identifier><language>eng</language><publisher>Los Angeles, CA: SAGE Publications</publisher><subject>Abdomen ; Adolescent ; Adult ; Aged ; Antibiotic Prophylaxis ; Antibiotics ; Catheters ; Cerebrospinal fluid ; Disease ; Dysphagia ; Endoscopy ; Female ; Fever ; Fistula ; Gastroscopy - adverse effects ; Gastroscopy - methods ; Gastrostomy - adverse effects ; Gastrostomy - methods ; Hemorrhage ; Humans ; Hydrocephalus ; Hypoxia ; Incidence ; Ischemia ; Leukocytes ; Male ; Middle Aged ; Neurological complications ; Neurosurgery ; Ostomy ; Patients ; Postoperative Complications - epidemiology ; Postoperative Complications - etiology ; Prophylaxis ; Retrospective Studies ; Shunts ; Staphylococcus infections ; Stroke ; Surgery ; Surgical outcomes ; Trauma ; Traumatic brain injury ; Tumors ; Ventriculoperitoneal shunt ; Ventriculoperitoneal Shunt - adverse effects ; Wound infection ; Young Adult</subject><ispartof>The American surgeon, 2024-12, Vol.90 (12), p.3262-3266</ispartof><rights>The Author(s) 2024</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c250t-1d3a366b6d2bcae19b320df107e1f7bc4c59b133f29c6509649e0334b591694b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/00031348241265147$$EPDF$$P50$$Gsage$$H</linktopdf><linktohtml>$$Uhttps://journals.sagepub.com/doi/10.1177/00031348241265147$$EHTML$$P50$$Gsage$$H</linktohtml><link.rule.ids>314,780,784,21818,27923,27924,43620,43621</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39030672$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Dexian</creatorcontrib><creatorcontrib>Peng, Run</creatorcontrib><creatorcontrib>Huang, Yebin</creatorcontrib><creatorcontrib>Zhou, Jun</creatorcontrib><creatorcontrib>Long, Zhihua</creatorcontrib><creatorcontrib>Wang, Jianjun</creatorcontrib><creatorcontrib>Zhang, Dejian</creatorcontrib><title>Safety Study of Percutaneous Gastroscopic Gastrostomy in Patients After Ventriculoperitoneal Shunt</title><title>The American surgeon</title><addtitle>Am Surg</addtitle><description>Objective
To evaluate the safety study of percutaneous gastroscopic gastrostomy in patients after ventriculoperitoneal shunt.
Methods
We conducted a retrospective analysis of neurosurgical patients who underwent VPS and PEG at our hospital between January 2012 and November 2023. Patients were divided into 2 groups: VPS group and VPS followed by PEG gruop. Patients received routine antibiotic prophylaxis before the procedure, continued for 48 hours. Follow-up included monitoring immediate complications, particularly wound infection, intracranial infection, neurologic status deterioration, and shunt dysfunction. Routine follow-up visits were conducted post-discharge.
Results
In the VPS group (n = 778), the incidence of intracranial infection was 3.08%. Among patients with PEG after VPS, the time interval between procedures ranged from 13 to 685 days. The mean follow-up period was 22 (1-77) months, with no deaths or further complications.
Conclusion
Performing PEG more than 13 days after VPS does not significantly increase the risk of intracranial infections or PEG-associated infections, making it a relatively safe procedure.</description><subject>Abdomen</subject><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Antibiotic Prophylaxis</subject><subject>Antibiotics</subject><subject>Catheters</subject><subject>Cerebrospinal fluid</subject><subject>Disease</subject><subject>Dysphagia</subject><subject>Endoscopy</subject><subject>Female</subject><subject>Fever</subject><subject>Fistula</subject><subject>Gastroscopy - adverse effects</subject><subject>Gastroscopy - methods</subject><subject>Gastrostomy - adverse effects</subject><subject>Gastrostomy - methods</subject><subject>Hemorrhage</subject><subject>Humans</subject><subject>Hydrocephalus</subject><subject>Hypoxia</subject><subject>Incidence</subject><subject>Ischemia</subject><subject>Leukocytes</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neurological complications</subject><subject>Neurosurgery</subject><subject>Ostomy</subject><subject>Patients</subject><subject>Postoperative Complications - epidemiology</subject><subject>Postoperative Complications - etiology</subject><subject>Prophylaxis</subject><subject>Retrospective Studies</subject><subject>Shunts</subject><subject>Staphylococcus infections</subject><subject>Stroke</subject><subject>Surgery</subject><subject>Surgical outcomes</subject><subject>Trauma</subject><subject>Traumatic brain injury</subject><subject>Tumors</subject><subject>Ventriculoperitoneal shunt</subject><subject>Ventriculoperitoneal Shunt - adverse effects</subject><subject>Wound infection</subject><subject>Young Adult</subject><issn>0003-1348</issn><issn>1555-9823</issn><issn>1555-9823</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kUtLxDAQx4Mo7vr4AF4k4MVLNZNp2uYo4gsWFFa9liRNtdJt1iQ97Lc3y_oAxdPMML_5z4uQI2BnAGV5zhhDwLziOfBCQF5ukSkIITJZcdwm03U-WwMTshfCWwrzhO2SCUqGrCj5lOi5am1c0XkcmxV1LX2w3oxRDdaNgd6oEL0Lxi078xVEt1jRbqAPKnZ2iIFetNF6-px835mxd0vru-gGq3o6fx2HeEB2WtUHe_hp98nT9dXj5W02u7-5u7yYZYYLFjNoUGFR6KLh2igLUiNnTQustNCW2uRGSA2ILZemEEwWubQMMddCQiFzjfvkdKO79O59tCHWiy4Y2_ebZWpkFa9QMOQJPfmFvrnRD2m6GoEDyAolJAo2lElrB2_beum7hfKrGli9fkD95wGp5vhTedQL23xXfF08AWcbIKgX-9P2f8UPda2NWQ</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Wang, Dexian</creator><creator>Peng, Run</creator><creator>Huang, Yebin</creator><creator>Zhou, Jun</creator><creator>Long, Zhihua</creator><creator>Wang, Jianjun</creator><creator>Zhang, Dejian</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>4T-</scope><scope>4U-</scope><scope>7QL</scope><scope>7T7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>202412</creationdate><title>Safety Study of Percutaneous Gastroscopic Gastrostomy in Patients After Ventriculoperitoneal Shunt</title><author>Wang, Dexian ; Peng, Run ; Huang, Yebin ; Zhou, Jun ; Long, Zhihua ; Wang, Jianjun ; Zhang, Dejian</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c250t-1d3a366b6d2bcae19b320df107e1f7bc4c59b133f29c6509649e0334b591694b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Abdomen</topic><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Antibiotic Prophylaxis</topic><topic>Antibiotics</topic><topic>Catheters</topic><topic>Cerebrospinal fluid</topic><topic>Disease</topic><topic>Dysphagia</topic><topic>Endoscopy</topic><topic>Female</topic><topic>Fever</topic><topic>Fistula</topic><topic>Gastroscopy - adverse effects</topic><topic>Gastroscopy - methods</topic><topic>Gastrostomy - adverse effects</topic><topic>Gastrostomy - methods</topic><topic>Hemorrhage</topic><topic>Humans</topic><topic>Hydrocephalus</topic><topic>Hypoxia</topic><topic>Incidence</topic><topic>Ischemia</topic><topic>Leukocytes</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neurological complications</topic><topic>Neurosurgery</topic><topic>Ostomy</topic><topic>Patients</topic><topic>Postoperative Complications - epidemiology</topic><topic>Postoperative Complications - etiology</topic><topic>Prophylaxis</topic><topic>Retrospective Studies</topic><topic>Shunts</topic><topic>Staphylococcus infections</topic><topic>Stroke</topic><topic>Surgery</topic><topic>Surgical outcomes</topic><topic>Trauma</topic><topic>Traumatic brain injury</topic><topic>Tumors</topic><topic>Ventriculoperitoneal shunt</topic><topic>Ventriculoperitoneal Shunt - adverse effects</topic><topic>Wound infection</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Dexian</creatorcontrib><creatorcontrib>Peng, Run</creatorcontrib><creatorcontrib>Huang, Yebin</creatorcontrib><creatorcontrib>Zhou, Jun</creatorcontrib><creatorcontrib>Long, Zhihua</creatorcontrib><creatorcontrib>Wang, Jianjun</creatorcontrib><creatorcontrib>Zhang, Dejian</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Docstoc</collection><collection>University Readers</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>The American surgeon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Dexian</au><au>Peng, Run</au><au>Huang, Yebin</au><au>Zhou, Jun</au><au>Long, Zhihua</au><au>Wang, Jianjun</au><au>Zhang, Dejian</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Safety Study of Percutaneous Gastroscopic Gastrostomy in Patients After Ventriculoperitoneal Shunt</atitle><jtitle>The American surgeon</jtitle><addtitle>Am Surg</addtitle><date>2024-12</date><risdate>2024</risdate><volume>90</volume><issue>12</issue><spage>3262</spage><epage>3266</epage><pages>3262-3266</pages><issn>0003-1348</issn><issn>1555-9823</issn><eissn>1555-9823</eissn><abstract>Objective
To evaluate the safety study of percutaneous gastroscopic gastrostomy in patients after ventriculoperitoneal shunt.
Methods
We conducted a retrospective analysis of neurosurgical patients who underwent VPS and PEG at our hospital between January 2012 and November 2023. Patients were divided into 2 groups: VPS group and VPS followed by PEG gruop. Patients received routine antibiotic prophylaxis before the procedure, continued for 48 hours. Follow-up included monitoring immediate complications, particularly wound infection, intracranial infection, neurologic status deterioration, and shunt dysfunction. Routine follow-up visits were conducted post-discharge.
Results
In the VPS group (n = 778), the incidence of intracranial infection was 3.08%. Among patients with PEG after VPS, the time interval between procedures ranged from 13 to 685 days. The mean follow-up period was 22 (1-77) months, with no deaths or further complications.
Conclusion
Performing PEG more than 13 days after VPS does not significantly increase the risk of intracranial infections or PEG-associated infections, making it a relatively safe procedure.</abstract><cop>Los Angeles, CA</cop><pub>SAGE Publications</pub><pmid>39030672</pmid><doi>10.1177/00031348241265147</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-1348 |
ispartof | The American surgeon, 2024-12, Vol.90 (12), p.3262-3266 |
issn | 0003-1348 1555-9823 1555-9823 |
language | eng |
recordid | cdi_proquest_miscellaneous_3082835032 |
source | MEDLINE; SAGE Complete A-Z List |
subjects | Abdomen Adolescent Adult Aged Antibiotic Prophylaxis Antibiotics Catheters Cerebrospinal fluid Disease Dysphagia Endoscopy Female Fever Fistula Gastroscopy - adverse effects Gastroscopy - methods Gastrostomy - adverse effects Gastrostomy - methods Hemorrhage Humans Hydrocephalus Hypoxia Incidence Ischemia Leukocytes Male Middle Aged Neurological complications Neurosurgery Ostomy Patients Postoperative Complications - epidemiology Postoperative Complications - etiology Prophylaxis Retrospective Studies Shunts Staphylococcus infections Stroke Surgery Surgical outcomes Trauma Traumatic brain injury Tumors Ventriculoperitoneal shunt Ventriculoperitoneal Shunt - adverse effects Wound infection Young Adult |
title | Safety Study of Percutaneous Gastroscopic Gastrostomy in Patients After Ventriculoperitoneal Shunt |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T18%3A32%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Safety%20Study%20of%20Percutaneous%20Gastroscopic%20Gastrostomy%20in%20Patients%20After%20Ventriculoperitoneal%20Shunt&rft.jtitle=The%20American%20surgeon&rft.au=Wang,%20Dexian&rft.date=2024-12&rft.volume=90&rft.issue=12&rft.spage=3262&rft.epage=3266&rft.pages=3262-3266&rft.issn=0003-1348&rft.eissn=1555-9823&rft_id=info:doi/10.1177/00031348241265147&rft_dat=%3Cproquest_cross%3E3121198391%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3121198391&rft_id=info:pmid/39030672&rft_sage_id=10.1177_00031348241265147&rfr_iscdi=true |